1. Faecal microbiota transplantation plus selected use of vancomycin for severe‐complicated Clostridium difficile infection: description of a protocol with high success rate. Issue 4 (19th June 2015) Authors: Fischer, M.; Sipe, B. W.; Rogers, N. A.; Cook, G. K.; Robb, B. W.; Vuppalanchi, R.; Rex, D. K. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 4(2015) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non‐HDL‐C levels. Issue 3 (28th November 2014) Authors: Corey, K. E.; Vuppalanchi, R.; Wilson, L. A.; Cummings, O. W.; Chalasani, N.; the NASH CRN Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 3(2015) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease. Issue 12 (25th April 2018) Authors: Chalasani, N.; Vuppalanchi, R.; Rinella, M.; Middleton, M. S.; Siddiqui, M. S.; Barritt, A. S.; Kolterman, O.; Flores, O.; Alonso, C.; Iruarrizaga‐Lejarreta, M.; Gil‐Redondo, R.; Sirlin, C. B.; Zemel, M. B. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 12(2018) Page Start: 1639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗